Aurinia Pharmaceuticals Inc股票 atpclks

Aurinia Pharmaceuticals Inc股票

08.11.2020

Gordin72267

Aurinia Pharmaceuticals Inc. Dividend policy. None. Price as of: Jun 5, 9:15 AM. $15.28 +0.1 +0.66%. AUPH: NASDAQ (Stock). Aurinia Pharmaceuticals Inc. Aurinia Pharmaceuticals Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Aurinia Pharmaceuticals Inc. Pharma stocks like Zymeworks Inc. (TSX:ZYME)( NYSE:ZYME) are coming into their own, offering growth investors a lot of upside Aurinia Pharmaceuticals Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. Get your free Aurinia Pharmaceuticals Inc stock live and up-to-date data - AUPH Quote, charts, rates, analysis, news & forecasts. Enter Now! View the latest AUPH stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of Aurinia Pharmaceuticals Inc.. 6 days ago Aurinia Pharmaceuticals Inc stock and Biotechnology market discussion, news, and analysis from Canada's largest community of active

Aurinia Pharmaceuticals Inc _安心de利帮您安心得利

Aurinia Pharmaceuticals Inc(usauph)股吧，股民朋友可以在这里畅所欲言，分析讨论股票名的最新动态。东方财富股吧，专业的股票论坛社区。 Aurinia Pharmaceuticals, Inc. (AUPH)

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing voclosporin, an investigational drug, for the treatment oflupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES).

Free real-time stock charts for Aurinia Pharmaceuticals Inc (AUPH). Analyze performance using advanced charting and trend analysis. Quotes Snapshot > AUPH. Aurinia Pharmaceuticals Inc AUPH:NASDAQ. Set Alert Options Streaming Charts. Last Price $14.98 NASDAQ Previous Close - Last Trade as of 4:15PM ET 6/05/20. Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) ("Aurinia" or the "Company"), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today A stock's Dividend Uptrend rating is dependent on the company's price-to-earnings (P/E) ratio to evaluate whether or not a stock's dividend is likely to trend upward. If a stock is valued near, or slightly below the market average, research has shown that the market expects the stock's dividend to increase. Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) stock closed at 15.43 per share at the end of the most recent trading day (a -2.03 % change compared to the prior day closing price) with a volume of 1.25M shares and market capitalization of 1.73B.Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 39 people. Aurinia Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of a therapeutic drug to treat autoimmune diseases. The company was founded Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Misses Revenue Estimates Aurinia (AUPH) delivered earnings and revenue surprises of 25.00% and -50.00%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Aurinia Pharmaceuticals, Inc. (auph)

AUPH-Aurnia制药股票行情，NASDAQ:AUPH股票价格，图表，新 … Shares in Aurinia Pharmaceuticals, Inc (AUPH) advanced in pre-market trading as the biotech company announced the submission of the New Drug Application (NDA) for its experimental voclosporin drug for the treatment kidney inflammation.The stock rose 3.1% to $1

Aurinia Pharmaceuticals Inc. (AUPH) Q1 2020 earnings call dated May. 14, 2020 Corporate Participants: Glenn Schulman -- Head of Investor Relations and Corporate Communications

提供Aurinia Pharmaceuticals Inc(AUPH)股票的行情走势、五档盘口、逐笔交易等实时行情数据，及Aurinia Pharmaceuticals Inc(AUPH)的资讯、公司公告、研究报告、行业研报、F10资料、行业资讯、资金流分析、阶段涨幅、所属板块、财务指标、机构观点、行业排名、估值水平、股吧互动等与Aurinia Pharmaceuticals Inc(AUPH 在 Yahoo 財經討論區查看最新的 Aurinia Pharmaceuticals Inc (AUPH) 股票討論內容。分享你的意見，並參考其他股票交易員和投資者的深入分析。